mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.005 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.006 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.008 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |